Mandibular Movement Monitoring in Children With Neurodisability.
Obstructive sleep apnoea (OSA) in children is diagnosed using polysomnography (PSG), but children with neurodisability are >3 times more likely to not tolerate leads and sensors. The diagnostic accuracy of Sunrise, a small sensor applied to the chin, has not been assessed in this special population.
Compare the diagnostic accuracy of Sunrise to simultaneously recorded in-laboratory PSG.
We conducted a prospective, cross-sectional study of children aged 3-18 years with neurodisability, who attended the Queensland Children's Hospital sleep laboratory for diagnostic PSG between February 2024 and September 2025. Sunrise- and PSG-derived measures of sleep disordered breathing were compared, and questionnaire data examining interest in novel sensor technology, and portable, home-based sleep studies were also collected.
There were 48 children with a neurodisability (mean [SD] age = 11.2 [3.6]; 39% female). For 43 children with complete Sunrise data, sensitivity and specificity for identifying moderate-severe obstructive sleep apnoea (OSA) using calibrated MM-ORDI were 0.88 (95% CI: 0.45-1.00) and 0.63 (95% CI: 0.45-0.79), respectively. The concordance correlation coefficient of the obstructive respiratory disturbance index was 0.65 (95% CI: 0.5-0.8) and the median absolute error was 5.7 (IQR: 2.7-13.1) events per hour. Most carers in attendance preferred in-laboratory sleep studies (56%) to home (33%), but the majority preferred Sunrise (50%) to limited-channel (17%) or full PSG (10%).
Sunrise shows excellent ability to exclude moderate-severe OSA in children with neurodisability with moderate specificity. There is substantial appetite among parents and carers for alternative sleep testing modalities.
Compare the diagnostic accuracy of Sunrise to simultaneously recorded in-laboratory PSG.
We conducted a prospective, cross-sectional study of children aged 3-18 years with neurodisability, who attended the Queensland Children's Hospital sleep laboratory for diagnostic PSG between February 2024 and September 2025. Sunrise- and PSG-derived measures of sleep disordered breathing were compared, and questionnaire data examining interest in novel sensor technology, and portable, home-based sleep studies were also collected.
There were 48 children with a neurodisability (mean [SD] age = 11.2 [3.6]; 39% female). For 43 children with complete Sunrise data, sensitivity and specificity for identifying moderate-severe obstructive sleep apnoea (OSA) using calibrated MM-ORDI were 0.88 (95% CI: 0.45-1.00) and 0.63 (95% CI: 0.45-0.79), respectively. The concordance correlation coefficient of the obstructive respiratory disturbance index was 0.65 (95% CI: 0.5-0.8) and the median absolute error was 5.7 (IQR: 2.7-13.1) events per hour. Most carers in attendance preferred in-laboratory sleep studies (56%) to home (33%), but the majority preferred Sunrise (50%) to limited-channel (17%) or full PSG (10%).
Sunrise shows excellent ability to exclude moderate-severe OSA in children with neurodisability with moderate specificity. There is substantial appetite among parents and carers for alternative sleep testing modalities.
Authors
Collaro Collaro, Sclip Sclip, Penny Penny, Mead Mead, Kevat Kevat, Chawla Chawla
View on Pubmed